Modifications of Hepatic Microsomal 9-Oxidation of N-2-Fluorenylacetamide in Response to Gonadectomy and Treatment of Rats with Phenobarbital or Diethylnitrosamine

References

• Aström A., DePierre J. W. Metabolism of 2‐acetylaminofluorene by eight different forms of cytochrome P‐450 isolated from rat liver. Carcinogenesis 1985; 6: 113–120
   PubMed Web of Science ®Google Scholar
• Benkert K., Fries W., Kiese M., Lenk W. N‐(9‐hydroxy‐9H‐fluoren‐2‐yl)‐acetamide and N‐(9‐oxo‐9H‐fluoren‐2‐yl)‐acetamide: Metabolites of N‐(9H‐fluoren‐2yl)‐acetamide. Biochemical Pharmacology 1975; 24: 1375–1380
   Web of Science ®Google Scholar
• Bock K. W., Burchell B., Dutton G. J., Hanninen O., Mulder G. J., Owens I. S., Siest G., Tephly T. R. UDP‐Glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochemical Pharmacology 1983; 32: 953–955
   PubMed Web of Science ®Google Scholar
• Dwivedi C., Downie A. A., Webb T. E. Net glucuronidation in different rat strains: importance of microsomal β‐Glucuronidase. FASEB Journal 1987; 1: 303–307
   PubMed Web of Science ®Google Scholar
• Kumaki K., Nebert D. W. Spectral evidence for weak ligand in sixth position of hepatic microsomal cytochrome P‐450 low spin ferric iron in vivo. Pharmacology 1978; 17: 262–279
   PubMed Web of Science ®Google Scholar
• Lamartiniere C. A., Dieringer C. S., Kita E., Lucier G. W. Altered sexual differentiation of hepatic uridine diphosphate glucuronyltransferase by neonatal hormone treatments in rats. Biochemical Journal 1979; 180: 313–318
   PubMed Web of Science ®Google Scholar
• Levvy G. A., Conchie J. β‐Glucuronidase and the hydrolysis of glucuronides. Glucuronic Acid, Free and Combined, G. J. Dutton. Academic Press, New York 1966; 301–364
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Lu A. Y. H., West S. B. Multiplicity of mammalian microsomal cytochromes P‐450. Pharmacological Reviews 1980; 31: 277–295
   Web of Science ®Google Scholar
• Malejka‐Giganti D., Decker R. W., Ritter C. L., Polovina M. R. Microsomal metabolism of the carcinogen, N‐2‐fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring‐ and N‐hydroxylations of N‐2‐fluorenylacetamide. Carcinogenesis 1985; 6: 95–103
   PubMed Web of Science ®Google Scholar
• Malejka‐Giganti D., Magat W. J., Decker R. W. Sex hormone‐mediated effects on the phase I and phase II metabolism of N‐2‐fluorenylacetamide: modulation of 9‐hydroxylation. Biochemical Pharmacology 1989; 38
   PubMed Web of Science ®Google Scholar
• Malejka‐Giganti D., Ritter C. L., Decker R. W., Suilman J. M. Peroxidative metabolism of a carcinogen, N‐hydroxy‐N‐2‐fluorenylacetamide, by rat uterus and mammary gland in vitro. Cancer Research 1986; 46: 6200–6206
   PubMed Web of Science ®Google Scholar
• Malejka‐Giganti D., Ryzewski C. N. Microsomal metabolism of the carcinogen, N‐2‐fluorenylacetamide, by the mammary gland and liver of female rats. II. Glucuronidation of ring‐and N‐hydroxylated metabolites of N‐2‐fluorenylacetamide. Carcinogenesis 1985; 6: 687–692
   PubMed Web of Science ®Google Scholar
• Matsubara T., Baron J., Peterson L. L., Peterson J. A. NADPH‐Cytochrome P‐450 reductase. Archives of Biochemistry and Biophysics 1976; 172: 463–469
   PubMed Web of Science ®Google Scholar
• Miller J. A. Carcinogenesis by chemicals: An overview‐G. H. A. Clowes Memorial Lecture. Cancer Research 1970; 30: 559–576
   PubMed Web of Science ®Google Scholar
• Miller J. A., Sandin R. B., Miller E. C., Rush H. P. The carcinogenicity of compounds related to 2‐acetylaminofluorene. II. Variations in the bridges and the 2‐substituent. Cancer Research 1955; 15: 183–199
   Web of Science ®Google Scholar
• Morris H. P., Velat C. A., Wagner B. P., Dahlgard M., Ray F. E. Studies of carcinogenicity in the rat of derivatives of aromatic amines related to N‐2‐fluorenylacetamide. Journal of the National Cancer Institute 1960; 24: 149–180
   PubMedGoogle Scholar
• Omura T., Sato R. The carbon monoxide‐binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Peraino C., Fry M. R. J., Staffeldt E., Kisieleski W. E. Effects of varying the exposure to phenobarbital on its enhancement of 2‐acetylaminofluorene‐induced hepatic tumorigenesis in the rat. Cancer Research 1973; 33: 2701–2705
   PubMed Web of Science ®Google Scholar
• Phillips A. H., Langdon R. G. Hepatic triphosphopyridine nucleotide‐cytochrome c reductase: Isolation, characterization and kinetic studies. Journal of Biological Chemistry 1962; 237: 2652–2660
   PubMed Web of Science ®Google Scholar
• Rinaudo J. A. S., Farber E. The pattern of metabolism of 2‐acetylaminofluorene in carcinogen‐induced hepatocyte nodules in comparison to normal liver. Carcinogenesis 1986; 7: 523–528
   PubMed Web of Science ®Google Scholar
• Solt D. B., Medline A., Farber E. Rapid emergence of carcinogen‐induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. American Journal of Pathology 1977; 88: 555–618
   Web of Science ®Google Scholar
• Son O. S., Fowbie J. W., Miller D. D., Feller D. R. 2‐Acetylaminofluorene metabolism in rat liver microsomes: Formation of 9‐hydroxy‐2‐acetylaminofluorene and effect of hepatic enzyme modifiers. Toxicology and Applied Pharmacology 1979; 51: 367–377
   PubMed Web of Science ®Google Scholar
• Steel R. G. D., Torrie J. H. Principles and Procedures of Statistics. McGraw‐Hill Book., Inc., New York 1960; 67–73
   Google Scholar
• Ullrich V., Schnabel K. H. Formation of ligand binding of the fluorenyl carbanion by hepatic cytochrome P‐450. Archives of Biochemistry and Biophysics 1973; 159: 240–248
   PubMed Web of Science ®Google Scholar
• Watkins J. B., Gregus Z., Thompson T. N., Klaassen C. D. Induction studies on the functional heterogeneity of rat liver UDP‐glucuronosyltransferases. Toxicology and Applied Pharmacology 1982; 64: 439–446
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Dannan G. A., Guengerich F. P. Regulation of rat hepatic cytochrome P‐450: Age‐dependent expression, hormonal imprinting, and xenobiotic inducibility of sex‐specific isoenzymes. Biochemistry 1985; 24: 4409–4417
   PubMed Web of Science ®Google Scholar
• Weisburger E. K., Weisburger J. H. A new route to 3‐ and 2,6‐substituted fluorenes. Journal of Organic Chemistry 1958; 23: 1193–1198
   Web of Science ®Google Scholar
• Weisburger J. H., Weisburger E. K., Grantham P. H., Morris H. P. N‐(6‐Hydroxy‐2‐fluorenyl)acetamide, a urinary metabolite after intraperitoneal injection of N‐2‐fluorenylacetamide into rats. Journal of Biological Chemistry 1959; 234: 2138–2140
   PubMed Web of Science ®Google Scholar
• Williams G. M. Classification of genotoxic and epigenetic hepatocarcinogens using liver culture assays. Annals of the New York Academy of Science 1980; 34: 273–282
   Google Scholar